@article{aa97291c7bfb4f1383dcf7f3d09e6e39,
title = "Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy",
keywords = "bortezomib, carfilomib, chimeric antigen receptor T cell refractory, multiple myeloma, selinexor",
author = "Ajai Chari and Vogl, {Dan T.} and Sundar Jagannath and Jagoda Jasielec and Unger, {Thaddeus J.} and Andrew DeCastro and Jatin Shah and Michael Kauffman and Sharon Shacham and Andrzej Jakubowiak",
note = "Funding Information: The authors would like to thank the patients who participated in these trials and their families, as well as the coinvestigators, nurses and study coordinators at each of the sites. In particular, Bernadette Libao at the University of Chicago, and Nicole Devito, Alexandra Dardac and Amishi Dhadwal at the Icahn School of Medicine at Mount Sinai are thanked for their support in data collection.",
year = "2020",
month = may,
day = "1",
doi = "10.1111/bjh.16550",
language = "English",
volume = "189",
pages = "e126--e130",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",
}